Back to Search Start Over

Phenotypic Expression, Natural History and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants

Authors :
Giovanni Maria Severini
Daniel P. Judge
Alessia PaldinoMD
Diane Fatkin
Chloe M. Reuter
Francesca Brun
Neal K. Lakdawala
Daniele Muser
Euan A. Ashley
J. Peter van Tintelen
Matthew R.G. Taylor
Ernesto E. Salcedo
Cynthia A. James
Arthur A.M. Wilde
Sylvia Turja
Brittney Murray
Hugh Calkins
Giulia De Angelis
D. Miani
Sharon L. Graw
Kermshlise Picard
Gianfranco Sinagra
Jean Jirikowic
William J. McKenna
Crystal Tichnell
Marta Gigli
Caterina Gregorio
Davide Stolfo
Anneline S.J.M. te Riele
Marco Merlo
Jiangping Song
Matteo Dal Ferro
Suet Nee Chen
Renee Johnson
Luisa Mestroni
Victoria N. Parikh
Gigli, Marta
Stolfo, Davide
Graw, Sharon
Merlo, Marco
Gregorio, Caterina
Chen, Suet Nee
Dal Ferro, Matteo
Paldino, Alessia
De Angelis, Giulia
Brun, Francesca
Jirikowic, Jean
Salcedo, Ernesto E
Turja, Sylvia
Fatkin, Diane
Johnson, Renee
van Tintelen, J Peter
Te Riele, Anneline S J M
Wilde, Arthur
Lakdawala, Neal K
Picard, Kermshlise
Miani, Daniela
Muser, Daniele
Severini, Giovanni Maria
Calkins, Hugh
James, Cynthia A
Murray, Brittney
Tichnell, Crystal
Parikh, Victoria N
Ashley, Euan A
Reuter, Chloe
Song, Jiangping
Judge, Daniel
Mckenna, William J
Taylor, Matthew R G
Sinagra, Gianfranco
Mestroni, Luisa
Cardiology
ACS - Heart failure & arrhythmias
Source :
Circulation, Circulation, 144(20), 1600-1611. Lippincott Williams and Wilkins
Publication Year :
2021

Abstract

Background: Filamin C truncating variants ( FLNCtv ) cause a form of arrhythmogenic cardiomyopathy: the mode of presentation, natural history, and risk stratification of FLNCtv remain incompletely explored. We aimed to develop a risk profile for refractory heart failure and life-threatening arrhythmias in a multicenter cohort of FLNCtv carriers. Methods: FLNCtv carriers were identified from 10 tertiary care centers for genetic cardiomyopathies. Clinical and outcome data were compiled. Composite outcomes were all-cause mortality/heart transplantation/left ventricle assist device (D/HT/LVAD), nonarrhythmic death/HT/LVAD, and sudden cardiac death/major ventricular arrhythmias. Previously established cohorts of 46 patients with LMNA and 60 with DSP -related arrhythmogenic cardiomyopathies were used for prognostic comparison. Results: Eighty-five patients carrying FLNCtv were included (42±15 years, 53% men, 45% probands). Phenotypes were heterogeneous at presentation: 49% dilated cardiomyopathy, 25% arrhythmogenic left dominant cardiomyopathy, 3% arrhythmogenic right ventricular cardiomyopathy. Left ventricular ejection fraction was FLNCtv carriers did not significantly differ from LMNA carriers and DSP carriers. In FLNCtv carriers, left ventricular ejection fraction was associated with the risk of D/HT/LVAD and nonarrhythmic death/HT/LVAD. Conclusions: Among patients referred to tertiary referral centers, FLNCtv arrhythmogenic cardiomyopathy is phenotypically heterogeneous and characterized by a high risk of life-threatening arrhythmias, which does not seem to be associated with the severity of left ventricular dysfunction.

Details

Language :
English
ISSN :
00097322
Database :
OpenAIRE
Journal :
Circulation, Circulation, 144(20), 1600-1611. Lippincott Williams and Wilkins
Accession number :
edsair.doi.dedup.....02cc43039286d3cef5962f7e632ea9b5
Full Text :
https://doi.org/10.1161/CIRCULATIONAHA.121.053521